What does CUSIP 05455M100 represent in this 13F holders report?

CUSIP 05455M100 is the security identifier for AVRO - AVROBIO INC - COM used to aggregate holder disclosures.

How many institutions held AVRO - AVROBIO INC - COM in Q4 2018?

58 institutional investors reported AVRO - AVROBIO INC - COM for Q4 2018. Use the holders table for investor-level position and value details.

AVROBIO INC - COM (AVRO)

CUSIP: 05455M100

Q4 2018 13F Holders as of 31 Dec 2018

Security type / class: Equity / COM
Total 13F shares: 16,638,472
Total 13F value: $276,460,341
Share change: +2,873,113
SEC-reported price per share: $16.65
Number of holders: 58
Value change: +$13,512,862
Number of buys: 33
Number of sells: 34

Security key

05455M100

Report period

Q4 2018

Institutions

Top holders

AVRO full security history Ownership snapshot Full 13F holder table Tectonic Therapeutic, Inc. SEC filings Tectonic Therapeutic, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AVRO - AVROBIO INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

SV Health Investors, LLC

Disclosed value leader

SV Health Investors, LLC

Comparable rows

0/15

Latest evidence

30 Sep 2018

13F Highest disclosed value: $141,918,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

SV Health Investors, LLC has the largest disclosed position value at $141.92M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SV Health Investors, LLC's linked filing trail.

Disclosed position value Top 5

SV Health Investors, LLC $141.92M

Cormorant Asset Management, LP $77.43M

CITADEL ADVISORS LLC $77.36M

EVENTIDE ASSET MANAGEMENT, LLC $46.42M

PRICE T ROWE ASSOCIATES INC /MD/ $41.6M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SV Health Investors, LLC	13F Company 13F	— denominator unverified	$141,918,000 2,736,027 shares	—	30 Sep 2018
Cormorant Asset Management, LP	13F Company 13F	— denominator unverified	$77,431,000 1,492,784 shares	—	30 Sep 2018
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$77,355,000 1,491,334 shares	—	30 Sep 2018
EVENTIDE ASSET MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$46,421,000 928,891 shares	—	30 Sep 2018
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	— denominator unverified	$41,601,000 802,015 shares	—	30 Sep 2018
JPMORGAN CHASE & CO	13F Company 13F	— denominator unverified	$27,871,000 537,322 shares	—	30 Sep 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

16,638,472

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

Q4 2018 holders

Holder diff

-4

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 value	Q4 2018 value	Value change	Value Chg %